MA Dong, DONG Qiu-mei, LIU Jian-hua. Comparation of Doxorubicin plus Sorafenib to Doxorubicin Alone in Patients with Advanced Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2012, 12(2): 106-108. DOI: 10.3969/j.issn.1671-5144.2012.02.015
|
Citation:
|
MA Dong, DONG Qiu-mei, LIU Jian-hua. Comparation of Doxorubicin plus Sorafenib to Doxorubicin Alone in Patients with Advanced Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2012, 12(2): 106-108. DOI: 10.3969/j.issn.1671-5144.2012.02.015
|
MA Dong, DONG Qiu-mei, LIU Jian-hua. Comparation of Doxorubicin plus Sorafenib to Doxorubicin Alone in Patients with Advanced Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2012, 12(2): 106-108. DOI: 10.3969/j.issn.1671-5144.2012.02.015
|
Citation:
|
MA Dong, DONG Qiu-mei, LIU Jian-hua. Comparation of Doxorubicin plus Sorafenib to Doxorubicin Alone in Patients with Advanced Hepatocellular Carcinoma[J]. Journal of Evidence-Based Medicine, 2012, 12(2): 106-108. DOI: 10.3969/j.issn.1671-5144.2012.02.015
|
DownLoad: